Generating ocean…
Identité
Therapeutics
Ocular Surface · A2A / A1
First ophthalmic innate-immune resolution therapy

The surface,
resolved.

A targeted therapy — one molecule that repairs, hydrates, and calms the ocular surface.
Scroll
Dwell 02

It holds,
then clears.

Held on the surface through the repair window — then it clears.

occupancy × dwell × interval
Binding 03

One molecule.
Two receptors.

A dual-receptor agonist that engages A2A and A1 on the ocular surface.

A2A + A1 · adenosine GPCRs
Cascade 04

The signal
propagates.

A2A raises cAMP through PKA — the relay behind both downstream effects.

Gαs → AC → cAMP → PKA
Resolution 05

Two axes,
one molecule.

Bicarbonate rebuilds the mucin gel; the inflamed macrophage shifts M1 → M2.

CFTR · HCO₃⁻ → mucin · M1→M2
Calm 06

The surface
calms.

Osmolarity falls, the tear film stabilizes, the surface recovers.

osmolarity · 316 → 301 mOsm/L*

Upstream of the surface-control loop.

Not another anti-inflammatory drop. A localized, pulsed, surface-restricted agonist of the body's own resolution signal.

IDENTITÉ Therapeutics